WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited

L. Boulter, R.V. Guest, T.J. Kendall, D.H. Wilson, D. Wojtacha, A.J. Robson, R.A. Ridgway, K. Samuel, N. van Rooijen, S.T. Barry, S.J. Wigmore, O.J. Sansom, S.J. Forbes

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1269-1285
JournalJournal of Clinical Investigation
Volume125
Issue number3
DOIs
Publication statusPublished - 2015

Cite this

Boulter, L., Guest, R. V., Kendall, T. J., Wilson, D. H., Wojtacha, D., Robson, A. J., ... Forbes, S. J. (2015). WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. Journal of Clinical Investigation, 125(3), 1269-1285. https://doi.org/10.1172/JCI76452